Physician variation in lung cancer treatment at the end of life.
CONCLUSIONS: Patients receiving care for aNSCLC in small independent oncology practices are more likely to receive chemotherapy in the last 30 days of life.
PMID: 28554208 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Green JB, Shapiro MF, Ettner SL, Malin J, Ang A, Wong MD Tags: Am J Manag Care Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Epidemiology | Health Management | Lung Cancer | Managed Care | Medicare | Non-Small Cell Lung Cancer | Study